Neurogene (NGNE) Ownership - Who Owns Neurogene?

626 Followers

Neurogene (NGNE) Ownership Overview

9.37% Insiders

6.69% Mutual Funds

69.14% Other Institutional Investors

10.08% ETFs

4.71% Public Companies and

Individual Investors

The ownership structure of Neurogene (NGNE) stock is a mix of institutional, retail, and individual investors. Approximately 85.91% of the company’s stock is owned by Institutional Investors, 9.37% is owned by Insiders, and 4.71% is owned by Public Companies and Individual Investors.

The ownership structure of Neurogene (NGNE) stock is a mix of institutional, retail, and individual investors. Approximately 75.83% of the company’s stock is owned by Institutional Investors, 9.37% is owned by Insiders, and 10.08% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 30, 2026	Rachel Mcminn	xxxxxxxxxxxxx	$73979
Mar 30, 2026	Christine Mikail Cvijic	xxxxxxxxxxxxx	$55304
Mar 30, 2026	Julie Jordan	xxxxxxxxxxxxx	$18125
Mar 17, 2026	Christine Mikail Cvijic	xxxxxxxxxxxxx	$84161

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	1,344,307	Insider	8.51%	40,880,376
Felix Baker	991,691	Institution	6.28%	30,157,323
	590,147	Institution	3.73%	17,946,370
	504,830	Institution	3.19%	15,351,880
	502,723	Institution	3.18%	15,287,806
	317,863	Institution	2.01%	9,666,214
	110,645	Institution	0.70%	3,364,714
	107,740	Institution	0.68%	3,276,373
	93,640	Insider	0.59%	2,847,592
	90,507	Institution	0.57%	2,752,318

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
502,723	Institution	3.18%	15,287,806
110,645	Institution	0.70%	3,364,714
107,740	Institution	0.68%	3,276,373
75,859	Institution	0.48%	2,306,872
56,386	Institution	0.36%	1,714,698
51,100	Institution	0.32%	1,553,951
30,058	Institution	0.19%	914,064
21,243	Institution	0.13%	646,000
18,781	Institution	0.12%	571,130
16,617	Institution	0.11%	505,323

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	382,191	Institution	2.42%	10,831,293
iShares Russell 2000 ETF	265,893	Institution	1.68%	7,995,403
Vanguard Extended Market ETF	120,632	Institution	0.76%	3,418,711
iShares Russell 2000 Value ETF	96,730	Institution	0.61%	2,908,671
Fidelity Enhanced Small Cap ETF	90,507	Institution	0.57%	2,793,046
iShares Biotechnology ETF	86,742	Institution	0.55%	2,608,332
Vanguard Russell 2000 ETF	57,993	Institution	0.37%	1,643,522
Xtrackers MSCI World Swap UCITS ETF	56,082	Institution	0.35%	1,730,691
Xtrackers MSCI World Swap UCITS ETF	56,082	Institution	0.35%	1,730,691
Xtrackers MSCI WORLD SWAP UCITS ETF Capitalisation 4C	56,082	Institution	0.35%	1,730,691

FAQ

Who Owns Neurogene (NGNE)?

According to the latest TipRanks data, approximately 69.14% of the company's stock is held by institutional investors, 9.37% is held by insiders, and 4.71% is held by retail investors.

What percentage of Neurogene (NGNE) stock is held by institutional investors?

According to the latest TipRanks data, approximately 69.14% of Neurogene (NGNE) stock is held by institutional investors.

What percentage of Neurogene (NGNE) stock is held by retail investors?

According to the latest TipRanks data, approximately 4.71% of Neurogene (NGNE) stock is held by retail investors.

Who owns the most shares of Neurogene (NGNE)?

Rachel Mcminn owns the most shares of Neurogene (NGNE).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.